American Heart News - Heart News
FEBRUARY 28, 2024
Research Highlights: An analysis of survey data for 430,000 adults in the U.S. found that using cannabis has a significant association with an increased risk of heart attack and stroke, independent of tobacco use, with higher odds among the adults.
Becker's Hospital Review - Cardiology
FEBRUARY 28, 2024
Discover the top 10 cardiology hospitals in the world, with seven based in the U.S. according to Newsweek's 2024 "World's Best Hospitals" list.
Med Page Today
FEBRUARY 28, 2024
(MedPage Today) -- Note that some links may require registration or subscription. In middle-age men with high Alzheimer's dementia risk, higher pancreatic fat was linked with lower cognition and brain volumes. (Obesity) The Department of Justice.
DAIC
FEBRUARY 28, 2024
Getty Images milla1cf Wed, 02/28/2024 - 19:13 February 28, 2024 — Artificial intelligence ( AI ) may transform cardiovascular medicine. For now, though, many challenges remain, and few AI tools have been proven to improve care, according to a new American Heart Association scientific statement published today in Circulation , the Association’s flagship, peer-reviewed journal.
HCPLive
FEBRUARY 28, 2024
MoodCapture, an app with AI that can detect depression onset from facial cues, accurately diagnosed 75% of participants in a study with early symptoms of depression.
DAIC
FEBRUARY 28, 2024
Wendy Bottinor, MD. Image courtesy of VCU Massey Comprehensive Cancer Center milla1cf Wed, 02/28/2024 - 19:24 February 28, 2024 — New research out of VCU Massey Comprehensive Cancer Center and VCU Health Pauley Heart Center indicates that survivors of childhood cancer are at a significantly higher risk of death following a major cardiovascular event — including heart failure , heart attack or stroke — than the general public.
HCPLive
FEBRUARY 28, 2024
This analysis emphasizes the necessity of prevention of melanoma as well as the public health and economic consequences of patients’ delaying of skin cancer diagnoses.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
Physiologically Speaking
FEBRUARY 28, 2024
Athens, Greece September 12, 490 BCE This is the site of the first known fatality related to endurance running. Upon arrival to Athens, running the now-revered distance of 26 miles (and change) to deliver a message of a military victory against the Persians, Pheidippides, our Greek hero, collapsed, most likely due to sheer exhaustion on behalf of his previous effort. “Joy to you, we’ve won” he said, and there and then he died, breathing his last breath with the words “Joy
Science Daily - Heart Disease
FEBRUARY 28, 2024
More frequent use of cannabis was associated with higher odds of adverse cardiovascular outcomes, finds new study.
Circulation
FEBRUARY 28, 2024
Circulation, Ahead of Print. A major focus of academia, industry, and global governmental agencies is to develop and apply artificial intelligence and other advanced analytical tools to transform health care delivery. The American Heart Association supports the creation of tools and services that would further the science and practice of precision medicine by enabling more precise approaches to cardiovascular and stroke research, prevention, and care of individuals and populations.
HCPLive
FEBRUARY 28, 2024
Viking Therapeutics' dual GLP-1/GIP receptor agonist VK2735 showed promising weight reduction in the phase 2 VENTURE trial, with the 15 mg dose contributing to a 14% reduction in body weight from baseline to week 13.
Journal of the American Heart Association
FEBRUARY 28, 2024
Journal of the American Heart Association, Ahead of Print. BackgroundWe examined the association between cannabis use and cardiovascular outcomes among the general population, among never‐tobacco smokers, and among younger individuals.Methods and ResultsThis is a population‐based, cross‐sectional study of 2016 to 2020 data from the Behavioral Risk Factor Surveillance Survey from 27 American states and 2 territories.
The New England Journal of Medicine
FEBRUARY 28, 2024
Cardiac rehabilitation provides evidence-based, secondary prevention after a cardiovascular event. This review addresses the benefits of cardiac rehabilitation programs and current barriers to participation.
Frontiers in Cardiovascular Medicine
FEBRUARY 28, 2024
Cangrelor, a potent intravenous P2Y12 platelet inhibitor, has demonstrated effectiveness in reducing ischemic events without a corresponding increase in severe bleeding during percutaneous coronary intervention, as evidenced by the CHAMPION-PHOENIX trial. Its off-label role as a bridging antiplatelet agent for patients facing high thrombotic risks who must temporarily stop oral P2Y12 inhibitor therapy further underscores its clinical utility.
American Heart News - Heart News
FEBRUARY 28, 2024
Statement Highlights: The American Heart Association encourages research and development of artificial intelligence (AI) and other related tools and services that may support and enable more precise approaches to cardiovascular and stroke research,
American College of Cardiology
FEBRUARY 28, 2024
The following are key points to remember from a state-of-the-art review on implications of atrial fibrillation (AF) for guideline-directed therapy in patients with heart failure (HF):
Circulation: Genomic and Precision Medicine
FEBRUARY 28, 2024
Circulation: Genomic and Precision Medicine, Ahead of Print. Dilated cardiomyopathy (DCM) is a common heart muscle disorder of nonischemic etiology associated with heart failure development and the risk of malignant ventricular arrhythmias and sudden cardiac death. A tailored approach to risk stratification and prevention of sudden cardiac death is required in genetic DCM given its variable presentation and phenotypic severity.
Frontiers in Cardiovascular Medicine
FEBRUARY 28, 2024
Background Cardiovascular diseases remain a leading cause of morbidity and mortality worldwide. Accurately predicting the 10-year risk of Atherosclerotic Cardiovascular Disease (ASCVD) is crucial for timely intervention and management. This study aimed to evaluate the predictive performance of six anthropometric indices in assessing the 10-year ASCVD risk.
HCPLive
FEBRUARY 28, 2024
No statistically significant differences in the odds of remission at ≤12 months were observed between patients receiving adalimumab compared with other biologics.
Frontiers in Cardiovascular Medicine
FEBRUARY 28, 2024
Background Our study aimed to develop machine learning algorithms capable of predicting red blood cell (RBC) transfusion during valve replacement surgery based on a preoperative dataset of the non-anemic cohort. Methods A total of 423 patients who underwent valvular replacement surgery from January 2015 to December 2020 were enrolled. A comprehensive database that incorporated demographic characteristics, clinical conditions, and results of preoperative biochemistry tests was used for establishi
Cardiovascular Diabetology
FEBRUARY 28, 2024
Type-2 diabetes (T2D) worsens stroke recovery, amplifying post-stroke disabilities. Currently, there are no therapies targeting this important clinical problem. Sodium-glucose cotransporter 2 inhibitors (SGLT2.
CardiacWire
FEBRUARY 28, 2024
Harvard researchers strengthened the link between high Lipoprotein(a) levels and greater risks of future cardiovascular events, including among patients who haven’t been diagnosed with ASCVD. The researchers analyzed 12-year outcomes from 16,419 people in the Mass General Brigham Lp(a) Registry who had their Lp(a) measured between 2000 to 2019, including 62% with a history of ASCVD (prior MI, revascularization, ischemic stroke).
Frontiers in Cardiovascular Medicine
FEBRUARY 28, 2024
Background As a therapy to prevent and treat essential hypertension (EH), traditional Chinese exercises (TCEs) were widely used in clinical practice. However, there is a lack of strictly comparison of the antihypertensive efficacy of different TCEs, which not conducive to the selection of the best and most optimal treatment. This study aimed to perform a network meta-analysis to objectively evaluate which TCE has the best effects in assisting with lowering blood pressure.
HCPLive
FEBRUARY 28, 2024
This announcement by UCB follows the results of four phase 3 studies on the use of bimekizumab for PsA, ankylosing spondylitis, and non-radiographic axial spondyloarthritis.
American College of Cardiology
FEBRUARY 28, 2024
The goal of the secondary analysis of the POP-HT trial was to determine the effect on cardiac remodeling of intensive, telehealth-based management of hypertension (HTN) versus usual postpartum care following hypertensive pregnancy.
HCPLive
FEBRUARY 28, 2024
A study from Brigham and Women's Hospital has identified 6 blood-based biomarkers that may predict cardiovascular disease risk in rheumatoid arthritis patients.
Science Daily - Heart Disease
FEBRUARY 28, 2024
A reusable vest that can map the electric impulses of the heart in fine detail could detect abnormalities from a potentially fatal heart disease much earlier than is currently possible, a new study suggests.
HCPLive
FEBRUARY 28, 2024
Inflammatory markers, infliximab levels, and physician global assessment scores remained similar when assessed pre- and post-switch to an infliximab biosimilar.
DAIC
FEBRUARY 28, 2024
Health technology giant Royal Philips has announced its proposal to appoint Charlotte Hanneman as member of the Board of Management to fulfill the role of Chief Financial Officer (CFO), filling the position held by Abhijit Bhattacharya, who will be retiring at the end of September after in that role since 2015. Image courtesy: Royal Philips christine.book Wed, 02/28/2024 - 11:30 February 28, 2024 — Royal Philips has announced the proposal to appoint Charlotte Hanneman as member of the Board of M
HCPLive
FEBRUARY 28, 2024
Hosts breakdown a pair of recent publications related to better understanding the strengths and limitations of MARD as well as a study comparing the Dexcom G7 and FreeStyle Libre 3 sensors.
CTVS
FEBRUARY 28, 2024
February is American Heart Month and we are highlighting some of the important therapies we work with often to aid in repairing and/or extend the life of the heart. Our board-certified cardiothoracic surgeons perform procedures day in and day out to improve heart health and save lives. Some of these include administering technologies such as ECMO and VAD.
HCPLive
FEBRUARY 28, 2024
Advanced practice providers in dermatology discuss exciting developments in the treatment landscape of plaque psoriasis. Listen to their insights into the often-challenging journey patients go on. The arrival of novel oral systemic treatment options offers opportunities to alleviate the burden of this chronic disease.
Frontiers in Cardiovascular Medicine
FEBRUARY 28, 2024
Background Pulmonary artery (PA) strain is associated with structural and functional alterations of the vessel and is an independent predictor of cardiovascular events. The relationship of PA strain to metabolomics in participants without cardiovascular disease is unknown. Methods In the current study, community-based older adults, without known cardiovascular disease, underwent simultaneous cine cardiovascular magnetic resonance (CMR) imaging, clinical examination, and serum sampling.
HCPLive
FEBRUARY 28, 2024
Patients perceived WelTel as a beneficial tool for providing quality care across domains including efficiency, safety, and patient-centeredness.
American College of Cardiology
FEBRUARY 28, 2024
In this week’s View, Dr. Eagle covers coronary calcium scores and how they predict ASCVD risk in the presence of left main disease and diabetes.
HCPLive
FEBRUARY 28, 2024
In an analysis of the DISCOVER-2 trial, guselkumab treatment reduced impairment in work productivity and improved general health status in PsA over 2 years.
Becker's Hospital Review - Cardiology
FEBRUARY 28, 2024
Stay up to date on the latest heart centers and programs receiving designations and accreditation in the last 90 days
Expert insights. Personalized for you.
145 
Let's personalize your content